AbelZeta
AbelZeta is a biotechnology company developing cell therapies for cancer and immune diseases, specializing in its CAR-T therapy platform.
Secondary Market Price
How AbelZeta Measures Up
To help you manage your AbelZeta equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series A
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of AbelZeta's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future AbelZeta Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for AbelZeta's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
AbelZeta Pharma is a biotechnology company engaged in the discovery, development, and manufacturing of cell therapies. The company focuses on creating proprietary T cell therapies, including CAR-T (Chimeric Antigen Receptor T-cell) treatments, to restore immune function. Its work targets unmet medical needs in hematologic malignancies, solid tumors, and inflammatory and immune diseases, with an emphasis on personalized medicine. Specific details about the company's history, such as its founding date or key milestones, are not available in the provided information.
Looking forward, AbelZeta's ongoing efforts are concentrated on the continued development of its T cell therapy platform for its target disease areas. While the company's website indicates the existence of a product pipeline and newsroom, specific details regarding future products, clinical trials, or recent announcements were not provided in the available source material.
- AstraZeneca
- HSG (formerly Sequoia Capital China)
- YF Capital
- GIC
- TF Capital
- Co-Founder, CEO Brain Schimpf
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is AbelZeta worth joining?
Deciding whether to join any startup depends on your personal career goals, risk tolerance, and the compensation package offered. Tools like Prospect can help you evaluate the financial upside by forecasting the potential value of your equity compensation.
What should I do with my AbelZeta stock?
Managing private stock involves complex decisions around when to exercise options, how to plan for taxes, and the right time to sell. Prospect provides personalized option exercise strategies and tax modeling to help you maximize your equity's value.
Can you sell AbelZeta stock?
As a private company, opportunities to sell AbelZeta stock are typically limited to company-approved events like tender offers or secondary market sales. Platforms like Prospect offer tender offer tools to help you navigate these opportunities and optimize your sale for taxes.
How can I find the value of my AbelZeta stock?
The value of private stock is not publicly listed and is typically determined by 409A valuations or the price set in a recent funding round. To get a more dynamic forecast, Prospect offers predictive models that project your equity's future value using investor-grade data.
What is AbelZeta's equity worth?
A private company's total equity value is based on its most recent valuation, which can change with new funding rounds and business performance. To understand what your personal stake in the company might be worth across different scenarios, you can use a platform like Prospect to model its potential value.
What is AbelZeta's stock ticker symbol?
As a private company, AbelZeta does not have a stock ticker symbol because its shares are not available on public stock exchanges. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO).
Can I buy or sell AbelZeta stock?
Buying shares in a private company like AbelZeta is usually restricted to accredited investors during funding rounds, while selling is subject to company restrictions. If you are an employee with equity, Prospect can help you plan for selling opportunities like tender offers or secondary sales.
What is the criteria to buy or invest in AbelZeta stock?
Investing in a private startup is typically limited to accredited investors, venture capital firms, or employees who receive equity as part of their compensation. Services like Prospect are designed to help employees manage the equity they already own, not to facilitate new investments.
